Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
February 14 2025 - 12:42PM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Schedule 13G Amendment No. 1 dated February 14, 2025 relating to the Common Stock, par value $0.001 per share, of Champions Oncology,
Inc. shall be filed on behalf of the undersigned.
|
TOCQUEVILLE ASSET MANAGEMENT L.P.
By: /s/ Kelsey Graham |
|
Name: Kelsey Graham |
|
Title: Chief Compliance Officer |
|
TAUBENPOST CAPITAL L.P.
By Taubenpost Capital LLC, its General Partner
By: /s/ Donald Wang |
|
Name: Donald Wang |
|
Title: Managing Member |
|
TAUBENPOST CAPITAL LLC
By: /s/ Donald Wang |
|
Name: Donald Wang |
|
Title: Managing Member |
|
DONALD WANG
By: /s/ Donald Wang |
Champions Oncology (NASDAQ:CSBR)
Historical Stock Chart
From Jan 2025 to Feb 2025
Champions Oncology (NASDAQ:CSBR)
Historical Stock Chart
From Feb 2024 to Feb 2025